[Management of Raynaud's phenomenon].
D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008019:Life Style; D011928:Raynaud Disease / Q000188:drug therapy / Q000628:therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D014665:Vasodilator Agents
La conduite à tenir face à un phénomène de Raynaud.